$GBCI SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Results of Operations and Financial Condition 1 Represents a non-GAAP financial measure. Supplemental “Non-GAAP Financial Measures and Reconciliations” tables are provided to reconcile the most directly comparable financial measure calculated and presented in accordance with GAAP.
31 Aug 2026	Form 4: Langel Craig A, Director Bought 2,250 shares ($106K)
31 Aug 2026	8-K: Regulation FD Disclosure; Other Events
07 Aug 2026	SCHEDULE 13G
04 Aug 2026	10-Q
03 Aug 2026	8-K: Regulation FD Disclosure
23 Jul 2026	8-K: Results of Operations and Financial Condition
05 May 2026	8-K: Regulation FD Disclosure
01 May 2026	8-K: Submission of Matters to a Vote of Security Holders; Regulation FD Disclosure
01 May 2026	FORM 10-Q
29 Apr 2026	SCHEDULE 13G
29 Apr 2026	SCHEDULE 13G
23 Apr 2026	8-K: Results of Operations and Financial Condition
26 Mar 2026	SCHEDULE 13G/A
13 Mar 2026	ARS
12 Mar 2026	Proxy statement: annual meeting on April 29, 2026 CEO pay $3.7M, up 25% · say-on-pay vote
25 Feb 2026	Form 4: Screnar Ryan Thomas, Chief Administrative Officer Bought 187 shares ($8.99K)
25 Feb 2026	10-K
18 Feb 2026	Form 4: Screnar Ryan Thomas, Chief Compliance Officer Received 4,501 shares as a grant or award · Gave up 713 shares to cover exercise price or tax
18 Feb 2026	Form 4: Chesler Randall M, Director Received 47,898 shares as a grant or award · Gave up 12,516 shares to cover exercise price or tax

Comments